Physician profile
Roberto C Jo
NPI 1629042403
$749.24
in general payments reported to CMS, 2019-2025
8 companies · $87.38 in 2025
The $87.38 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $34.22 · 2021: $69.12 · 2022: $127 · 2023: $218 · 2024: $34.73 · 2025: $87.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $198.14 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $176.24 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $121.38 | 2019-2024 | |
| Glaxosmithkline, LLC. | $95.51 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.58 | 2022-2023 | Stiolto Respimat, Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.21 | 2019 | |
| Heartflow, INC. | $24.18 | 2025 | |
| Amgen INC. | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Jo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.